TRAVERE THERAPEUTICS (BILE ACID PRODUCT PORTFOLIO)

Summary

Travere’s bile acid product portfolio includes Cholbam® (cholic acid) and Chenodal® (chenodiol), two medications addressing rare diseases in high-need settings.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 367 M

Avg. Deal Size£ 367 M

Market Context